{"id":"https://openalex.org/W1991453776","doi":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","title":"Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes","display_name":"Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes","publication_year":1999,"publication_date":"1999-07-01","ids":{"openalex":"https://openalex.org/W1991453776","doi":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","mag":"1991453776","pmid":"https://pubmed.ncbi.nlm.nih.gov/10403914","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1905462"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2249.1999.00900.x","doi":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1905462/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059918331","display_name":"Stanislava Sto\u0161i\u0107\u2010Gruji\u010di\u0107","orcid":"https://orcid.org/0000-0002-9845-3299","observed_orcids":["https://orcid.org/0000-0002-9845-3299"]},"institutions":[{"id":"https://openalex.org/I4400009014","display_name":"Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d","ror":"https://ror.org/044qmqe70","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193","https://openalex.org/I4400009014"]}],"countries":["RS"],"is_corresponding":true,"raw_author_name":"S STOSIC-GRUJICIC","raw_affiliation_strings":["Institute for Biological Research \u2018Sinisa Stankovic\u2019","Institute for Biological Research 'Sinisa Stankovic', Department of Microbiology and Immunology, University School of Pharmacy, Belgrade, Yugoslavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Biological Research \u2018Sinisa Stankovic\u2019","institution_ids":["https://openalex.org/I4400009014"]},{"raw_affiliation_string":"Institute for Biological Research 'Sinisa Stankovic', Department of Microbiology and Immunology, University School of Pharmacy, Belgrade, Yugoslavia","institution_ids":["https://openalex.org/I4400009014"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002199811","display_name":"Miroslava Dimitrijevic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4068193","display_name":"University of Belgrade","ror":"https://ror.org/02qsmb048","country_code":"RS","type":"education","lineage":["https://openalex.org/I4068193"]}],"countries":["RS"],"is_corresponding":false,"raw_author_name":"M DIMITRIJEVIC","raw_affiliation_strings":["Department of Microbiology and Immunology, University School of Pharmacy, Belgrade, Yugoslavia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology and Immunology, University School of Pharmacy, Belgrade, Yugoslavia","institution_ids":["https://openalex.org/I4068193"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111780119","display_name":"R. R. Bartlett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R BARTLETT","raw_affiliation_strings":["Immunopharmacology, Hoechst AG Werk Kalle-Albert, Wiesbaden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunopharmacology, Hoechst AG Werk Kalle-Albert, Wiesbaden, Germany","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5059918331"],"corresponding_institution_ids":["https://openalex.org/I4400009014"],"apc_list":{"value":2894,"currency":"GBP","value_usd":3816},"apc_paid":null,"fwci":1.3607,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.78536747,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"117","issue":"1","first_page":"44","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leflunomide","display_name":"leflunomide","score":1.0},{"id":"https://openalex.org/keywords/a771726","display_name":"A771726","score":0.9480000138282776},{"id":"https://openalex.org/keywords/multiple-low-dose-streptozotocin","display_name":"multiple low-dose streptozotocin","score":0.8840000033378601},{"id":"https://openalex.org/keywords/insulitis","display_name":"insulitis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/experimental-autoimmune-diabetes","display_name":"experimental autoimmune diabetes","score":0.7239999771118164},{"id":"https://openalex.org/keywords/isoxazolidine-derivatives","display_name":"isoxazolidine derivatives","score":0.5839999914169312},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8149999976158142},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/islet-destruction","display_name":"islet damage","score":0.8220000267028809},{"id":"https://openalex.org/keywords/cba-h-mice","display_name":"CBA/H mice","score":0.6729999780654907},{"id":"https://openalex.org/keywords/autoimmune-inflammatory-disease","display_name":"autoimmune inflammatory disease","score":0.3100000023841858}],"concepts":[{"id":"https://openalex.org/C2775905006","wikidata":"https://www.wikidata.org/wiki/Q248550","display_name":"Leflunomide","level":3,"score":0.9018612504005432},{"id":"https://openalex.org/C2779511750","wikidata":"https://www.wikidata.org/wiki/Q922215","display_name":"Insulitis","level":4,"score":0.6588377356529236},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.603900134563446},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5097257494926453},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5056822299957275},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.500922441482544},{"id":"https://openalex.org/C167464567","wikidata":"https://www.wikidata.org/wiki/Q1775422","display_name":"Mononuclear cell infiltration","level":2,"score":0.49563825130462646},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.4905363917350769},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.4843643605709076},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.4587557315826416},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.45365869998931885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38730600476264954},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.340248167514801},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2914448380470276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21754378080368042},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20377960801124573},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.20164459943771362},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.12982144951820374},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077339","descriptor_name":"Leflunomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007515","descriptor_name":"Islets of Langerhans","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008808","descriptor_name":"Mice, Inbred CBA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010195","descriptor_name":"Pancreatitis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013311","descriptor_name":"Streptozocin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052247","descriptor_name":"Nitric Oxide Synthase Type II","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1046/j.1365-2249.1999.00900.x","doi":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2249.1999.00900.x","pdf_url":null,"source":{"id":"https://openalex.org/S11896317","display_name":"Clinical & Experimental Immunology","issn_l":"0009-9104","issn":["0009-9104","1365-2249"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"journal-article"},{"id":"pmid:10403914","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10403914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical and experimental immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1905462","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1905462/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},{"id":"pmh:oai:ibiss-r.rcub.bg.ac.rs:123456789/1844","doi":null,"is_oa":false,"landing_page_url":"http://ibiss-r.rcub.bg.ac.rs/123456789/1844","pdf_url":null,"source":{"id":"https://openalex.org/S4306401922","display_name":"Digital Repository of Archived Publications (University of Belgrade, Institute for Biological Research Sinisa Stankovic)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210101313","host_organization_name":"University Hospital Center Dr Dragi\u0161a Mi\u0161ovi\u0107","host_organization_lineage":["https://openalex.org/I4210101313"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Immunology","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1905462","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1905462/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Exp Immunol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1502688016","https://openalex.org/W1505646153","https://openalex.org/W1629295194","https://openalex.org/W1888797325","https://openalex.org/W1913275399","https://openalex.org/W1929268745","https://openalex.org/W1959097863","https://openalex.org/W1989683612","https://openalex.org/W1992301407","https://openalex.org/W1993966189","https://openalex.org/W2001436166","https://openalex.org/W2003118643","https://openalex.org/W2010357177","https://openalex.org/W2042954145","https://openalex.org/W2056224427","https://openalex.org/W2065773091","https://openalex.org/W2084039618","https://openalex.org/W2088876216","https://openalex.org/W2122332000","https://openalex.org/W2122845474","https://openalex.org/W2156990969","https://openalex.org/W2157279574","https://openalex.org/W2163155271","https://openalex.org/W2416591679","https://openalex.org/W4285719527","https://openalex.org/W4313333698"],"related_works":["https://openalex.org/W2416591679","https://openalex.org/W2102905137","https://openalex.org/W2012944711","https://openalex.org/W1517359748","https://openalex.org/W2316378674","https://openalex.org/W2022866756","https://openalex.org/W2071895801","https://openalex.org/W2144933864","https://openalex.org/W2339564449","https://openalex.org/W7100298348"],"abstract_inverted_index":{"In":[0,20],"certain":[1],"animal":[2],"models":[3],"of":[4,27,31,55,69,97,122,133,136,152,164,181,186,189,196,229,235,246,251],"autoimmunity":[5],"the":[6,21,24,28,93,98,134,161,165,173,187,193,210,257],"isoxasol":[7],"derivative":[8],"leflunomide":[9,70,247],"has":[10],"been":[11],"reported":[12],"to":[13],"exert":[14],"a":[15,141,249,262],"protective":[16],"effect":[17],"against":[18],"autodestruction.":[19],"present":[22],"study,":[23],"immunomodulatory":[25,231],"potential":[26],"main":[29],"metabolite":[30],"leflunomide,":[32],"A77":[33,85,148,190],"1726,":[34],"in":[35,46,140,217,248],"experimentally":[36],"induced":[37,45],"autoimmune":[38,174,267],"diabetes":[39,253],"was":[40,44,176],"investigated.":[41],"The":[42],"disease":[43,99,108,175],"genetically":[47],"susceptible":[48],"CBA/H":[49],"mice":[50,77,207],"by":[51,73,115],"multiple":[52],"low":[53],"doses":[54],"streptozotocin":[56],"(MLD-SZ,":[57],"40":[58],"mg/kg":[59,154,168],"per":[60,155,169],"day,":[61],"given":[62],"intraperitoneally":[63,83],"for":[64,87,266],"5":[65],"consecutive":[66,89],"days).":[67],"Effects":[68],"were":[71,81,138],"evaluated":[72],"two":[74],"treatment":[75,146,159],"protocols:":[76],"treated":[78],"with":[79,84,147,160],"MLD-SZ":[80],"injected":[82],"1726":[86,149,191],"10":[88,95,106],"days,":[90],"either":[91],"during":[92],"first":[94],"days":[96],"(early":[100],"treatment),":[101],"or":[102,198],"starting":[103],"from":[104,203],"day":[105],"after":[107,144],"induction":[109],"(late":[110],"treatment).":[111],"Disease":[112],"manifestations":[113],"defined":[114],"hyperglycaemia,":[116],"mononuclear":[117,201,220],"infiltration":[118],"into":[119],"pancreas,":[120],"expression":[121],"interferon-gamma":[123],"(IFN-gamma)":[124],"and":[125,131,205,216,243,254],"inducible":[126],"nitric":[127],"oxide":[128],"synthase":[129],"(iNOS)":[130],"destruction":[132],"islets":[135],"Langerhans":[137],"reduced":[139],"dose-dependent":[142],"fashion":[143],"early":[145],"(dose":[150],"range":[151],"5-35":[153],"day).":[156],"Moreover,":[157],"late":[158],"high":[162],"dose":[163],"drug":[166,211,258],"(25":[167],"day),":[170],"started":[171],"when":[172],"already":[177],"apparent,":[178],"arrested":[179],"progression":[180],"ongoing":[182],"inflammatory":[183,268],"response.":[184],"Analysis":[185],"effects":[188,245],"on":[192],"adhesive":[194,236],"interactions":[195],"spleen-derived":[197],"peripheral":[199],"blood-derived":[200],"cells":[202],"MLD-SZ-treated":[204],"normal":[206],"demonstrated":[208],"that":[209,225,256],"inhibits":[212],"both":[213,241],"ex":[214],"vivo":[215],"vitro":[218],"spontaneous":[219],"cell":[221],"aggregation,":[222],"thus":[223],"suggesting":[224],"an":[226],"important":[227],"component":[228],"leflunomide's":[230],"action":[232],"is":[233],"suppression":[234],"interactions.":[237],"These":[238],"results":[239],"demonstrate":[240],"preventive":[242],"therapeutic":[244,264],"model":[250],"MLD-SZ-induced":[252],"suggest":[255],"may":[259],"be":[260],"considered":[261],"potent":[263],"tool":[265],"disorders,":[269],"including":[270],"diabetes.":[271]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}